July 01, 2020
Andrew Glazer, Ph.D., is a postdoctoral fellow in the Division of Clinical Pharmacology at Vanderbilt University Medical Center. His research is centered around genetic variations that underlie rare Mendelian diseases, with particular focus on arrhythmia syndromes.
